'Huge' Survival Benefit, New Standard of Care in Glioma'Huge' Survival Benefit, New Standard of Care in Glioma

Adding adjuvant temozolomide to radiotherapy for patients with grade 3 anaplastic glioma without the 1p/19 deletion is a new standard of care. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news